THERAVANCE BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.29 USD | -3.23% |
|
-0.96% | -17.35% |
| May. 13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
| May. 13 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Other Pharmaceuticals | -3.23% | -0.96% | -17.35% | -13.90% | -54.95% | 467M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- TBPH Stock
- Charts Theravance Biopharma, Inc.
- Comparison Chart
